Expert NetworkExpert InterviewKPTI

Slingshot members are talking to an expert! The topic is:

Discussing the ASCO 2022 poster "A phase 1, open-label, dose-escalation study of selinexor plus ruxolitinib in patients with treatment-naïve myelofibrosis" from Karyopharm Therapeutics

Executed on:Apr 3, 2023 12:00 PM EDT
Call Duration:30 minutes

Expert Profile

ExpertBlinded Expert
Institution: University of Utah
  • Professor in the Division of Hematology and Hematologic Malignancies & Huntsman Cancer Institute Investigator at the University of Utah.
  • Member of the Cell Response and Regulation Program and the Imaging, Diagnostics, and Therapeutics Program.
  • Research focuses on elucidating the molecular basis of hematological diseases to discover their either somatic or germline underlying mutations and then determine the functions of the mutations.

Interview Goal

To discuss the existing data, and expectations from the updated results to be presented at AACR

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.